SOMCL-171

N/A

Report date: 2023/05/22 10:18:15
NME

Base Information

Drug NameSOMCL-171
Drug Alias NameSOMCL-171
ClassificationSmall molecules
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsDopamine D2 receptor partial agonists
TargetsSerotonin 1a (5-HT1a) receptorDopamine D2 receptor
Therapy Area/IndicationsDyskinesia, Drug-Induced
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Active IndicationsN/A
Inactive IndicationsDyskinesia, Drug-Induced

Other Information

ATC CodeN/A
Related LinksN/A